Drug Shortage Report for AVALIDE

Last updated on 2022-04-20 History
Report ID 158890
Drug Identification Number 02241819
Brand name AVALIDE
Common or Proper name Irbesartan and Hydrochlorothiazide Tablets
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 12.5MG 300MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size Bottle of 90 tablets
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-04-19
Estimated end date 2022-06-30
Actual end date
Shortage status Actual shortage
Updated date 2022-04-20
Company comments Manufacturing Issue. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-04-14 English Compare
v2 2022-04-14 French Compare
v3 2022-04-14 English Compare
v4 2022-04-14 French Compare
v5 2022-04-20 English Compare

Showing 1 to 5 of 5